Financials
- Market Capitalization 1.9 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-83.55
ratio cours/chiffre d'affaires
3.77
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2011 | VIR Vir Biotechnology, Inc. - Common Stock | 11.63 USD | +6.31% | +9.72% | +33.07% | +94.48% | 1.97 B USD | ||
| 2028 | NBTX Nanobiotix S.A. - ADSs | 39.29 USD | -3.32% | -4.94% | +4.58% | +329.87% | 1.90 B USD | ||
| 2032 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.30 USD | -4.45% | -17.51% | +10.61% | +211.97% | 1.90 B USD | ||
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -7.32% | -3.23% | +100.70% | 1.86 B USD |